Lvw Advisors, LLC Bei Gene, Ltd. Transaction History

Lvw Advisors, LLC

$916 Million
Q3 2025

A detailed history of Lvw Advisors, LLC transactions in Bei Gene, Ltd. stock. As of the latest transaction made, Lvw Advisors, LLC holds 952 shares of BGNE stock, worth $215,827. This represents 0.02% of its overall portfolio holdings.

Number of Shares

952

Previous 1,022 6.85%

Holding current value

$215,827

Previous $231,000 6.93%

% of portfolio

0.02%

Previous 0.03%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Oct 20, 2025	SELL	N/A	-70 Reduced 6.85%	952 $215,000
Q2 2025 Jul 16, 2025	SELL	N/A	-7 Reduced 0.68%	1,022 $231,000
Q1 2025 Apr 09, 2025	SELL	$175.1 - $226.71 $18,035 - $23,351	-103 Reduced 9.1%	1,029 $233,000
Q4 2024 Jan 16, 2025	BUY	$174.72 - $246.04 $22,888 - $32,231	131 Added 13.09%	1,132 $209,000
Q3 2024 Oct 09, 2024	SELL	$143.93 - $224.51 $140,763 - $219,570	-978 Reduced 49.42%	1,001 $224,000

Q2 2024 Jul 15, 2024	BUY	$129.52 - $174.32 $2,849 - $3,835	22 Added 1.12%	1,979 $282,000
Q1 2024 Apr 17, 2024	BUY	$141.8 - $181.47 $92,737 - $118,681	654 Added 50.19%	1,957 $306,000
Q4 2023 Jan 12, 2024	SELL	$158.67 - $201.58 $29,829 - $37,897	-188 Reduced 12.61%	1,303 $235,000
Q3 2023 Oct 10, 2023	SELL	$179.87 - $225.13 $56,299 - $70,465	-313 Reduced 17.35%	1,491 $268,000
Q2 2023 Jul 14, 2023	SELL	$178.3 - $266.78 $2,674 - $4,001	-15 Reduced 0.82%	1,804 $321,000
Q1 2023 May 02, 2023	BUY	$215.53 - $274.5 $29,096 - $37,057	135 Added 8.02%	1,819 $392,000
Q4 2022 Jan 18, 2023	BUY	$125.51 - $229.3 $10,668 - $19,490	85 Added 5.32%	1,684 $0
Q3 2022 Oct 13, 2022	SELL	$131.8 - $202.24 $7,249 - $11,123	-55 Reduced 3.33%	1,599 $216,000
Q2 2022 Jul 22, 2022	SELL	$121.11 - $216.05 $8,598 - $15,339	-71 Reduced 4.12%	1,654 $268,000
Q1 2022 May 02, 2022	SELL	$146.52 - $269.56 $10,842 - $19,947	-74 Reduced 4.11%	1,725 $325,000
Q4 2021 Jan 26, 2022	SELL	$248.56 - $389.34 $47,972 - $75,142	-193 Reduced 9.69%	1,799 $487,000
Q3 2021 Nov 02, 2021	BUY	$249.6 - $403.14 $16,972 - $27,413	68 Added 3.53%	1,992 $723,000
Q2 2021 Jul 15, 2021	BUY	$292.75 - $367.01 $6,440 - $8,074	22 Added 1.16%	1,924 $660,000
Q1 2021 Apr 19, 2021	BUY	$260.64 - $382.12 $81,840 - $119,985	314 Added 19.77%	1,902 $662,000
Q4 2020 Feb 04, 2021	BUY	$221.31 - $316.61 $77,679 - $111,130	351 Added 28.38%	1,588 $410,000
Q3 2020 Oct 29, 2020	BUY	$189.18 - $286.44 $234,015 - $354,326	1,237 New	1,237 $354,000

Others Institutions Holding BGNE

# of Institutions

297

Shares Held

30.4M

Call Options Held

147K

Put Options Held

195K

View Full List

About BeiGene, Ltd.

Ticker BGNE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 103,700,000
Market Cap $23.5B
Description
BeiGene, Ltd., a biotechnology company, focuses on discovering, developing, manufacturing, and commercializing various medicines worldwide. Its products include BRUKINSA to treat relapsed/refractory (R/R) mantle cell lymphoma; Tislelizumab to treat R/R classical Hodgkin's lymphoma; REVLIMID to treat multiple myeloma; VIDAZA to treat myelodysplas...

More about BGNE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lvw Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lvw Advisors, LLC with notifications on news.

Account